PhRMA Wants Tariff Elimination On Rx Sales To Developing Countries
Executive Summary
Elimination of all tariffs on sales of pharmaceuticals exported to developing countries is among the Pharmaceutical Research & Manufacturers of America's agenda items for the G8 trade summit.
You may also be interested in...
Senate Re-Importation Bill Opposed By Wholesalers, Chains; NCPA Supports
The record-keeping provisions in Sen. Jeffords' (R-Vt.) pharmaceutical importation amendment are drawing opposition from the large wholesaler and chain drug trade associations.
Africa AIDS Drug Program Relies On NGOs To Achieve Secure Distribution
Five of the major AIDS drug marketers are counting on the leading non-governmental organizations to develop secure distribution systems for drugs supplied to developing countries.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011